Global Hepatitis A and B Vaccine Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 0.8 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030.
The global Hepatitis A and B vaccine market is witnessing steady growth as healthcare professionals and governments intensify efforts to curb the spread of these viral infections. Hepatitis A and B are major causes of liver disease, and immunization has proven to be one of the most effective ways to reduce transmission. According to recent market analysis, the increasing prevalence of these viruses, especially in developing regions, coupled with rising healthcare awareness, is driving the demand for vaccines. Market forecasts indicate that the global Hepatitis A and B vaccine market is set to expand significantly over the next few years.
Hepatitis A is a contagious liver disease caused by the Hepatitis A virus (HAV), typically spread through contaminated food or water. Hepatitis B, on the other hand, is a viral infection transmitted through contact with infected bodily fluids. Both diseases can lead to severe liver complications, including cirrhosis, liver failure, and cancer. Vaccination is a key strategy to prevent these infections, and the increasing availability of combination vaccines (Hepatitis A and B) is making immunization more convenient for the public.
The market for Hepatitis A and B vaccines is being driven by rising vaccination campaigns, government initiatives, and increased global focus on public health. Developed countries are witnessing a higher uptake due to better access to healthcare services, while low- and middle-income countries are seeing increased immunization efforts supported by global organizations. Additionally, the introduction of new vaccine formulations and advancements in vaccine storage and distribution are expected to further boost market growth.
As of 2025, North America is leading the market in terms of revenue, followed closely by Europe and the Asia Pacific region. The growing awareness about preventive healthcare, alongside government mandates for vaccination in schools and travel advisories, is helping expand the market across different geographies.
Get an In-Depth Research Analysis of the Global Hepatitis A and B Vaccine Market Size And Forecast [2025-2032]
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Hepatitis A and B Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Hepatitis A and B Vaccine Market
Government Institution
Private Sector
Other
Based on Types the Market is categorized into Below types that held the largest Hepatitis A and B Vaccine market share In 2023.
Hepatitis A Vaccination
Hepatitis B Vaccination
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Hepatitis A and B Vaccine Market Research Analysis
1. Introduction of the Global Hepatitis A and B Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Hepatitis A and B Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Hepatitis A and B Vaccine Market, By Type
6. Global Hepatitis A and B Vaccine Market, By Application
7. Global Hepatitis A and B Vaccine Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Hepatitis A and B Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/